Acadia Healthcare Company, Inc. (ACHC) 2015 Q2 法說會逐字稿

完整原文

使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主

  • Operator

    Operator

  • As a reminder this call is being recorded. Please proceed.

    提醒各位,本次電話會議正在錄音。請繼續。

  • Brent Turner - President

    Brent Turner - President

  • Good morning. I'm Brent Turner, President of Acadia Healthcare, and I'd like to welcome you to our second-quarter 2015 conference call. To the extent any non-GAAP financial measure is discussed in today's call you will also find a reconciliation of that measure to the most directly comparable financial measure calculated according to GAAP on our website by viewing yesterday's news release under the investors link.

    各位早安。我是 Acadia Healthcare 總裁 Brent Turner,歡迎各位參加我們 2015 年第二季電話法說會。若今日電話會議中討論到任何非 GAAP 財務衡量指標,您也可在我們網站上,透過投資人連結查看昨日新聞稿,以取得該指標與依 GAAP 計算之最直接可比財務衡量指標的調節表。

  • This conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including statements, among others, regarding Acadia's expected quarterly and annual financial performance for 2015 and beyond. For this purpose any statements made during this call that are not statements of historical fact may be deemed to be forward-looking statements.

    本次電話會議可能包含《1995 年私人證券訴訟改革法》所定義的前瞻性陳述,包括但不限於有關 Acadia 對 2015 年及其後各季度與年度預期財務表現的陳述。就此而言,本次電話會議中任何非歷史事實的陳述,均可能被視為前瞻性陳述。

  • Without limiting the foregoing the words believes, anticipates, plans, expects, and similar expressions are intended to identify forward-looking statements. You are hereby cautioned that these statements may be affected by the important factors, among others, set forth in Acadia's filings with the Securities and Exchange Commission and in the Company's second-quarter news release and, consequently, actual operations and results may differ materially from the results discussed in the forward-looking statements.

    在不限制前述內容之前提下,「相信」、「預期」、「計畫」、「預估」及類似用語旨在辨識前瞻性陳述。特此提醒您,這些陳述可能受到多項重要因素影響(包括但不限於 Acadia 向美國證券交易委員會提交之文件以及公司第二季新聞稿中所載因素),因此實際營運與結果可能與前瞻性陳述中討論之結果存在重大差異。

  • The Company undertakes no obligation to update publicly any forward-looking statements whether as a result of new information, future events or otherwise. At this time, for opening remarks, I will now turn the conference over to our Chairman and Chief Executive Officer, Joey Jacobs.

    本公司不承擔公開更新任何前瞻性陳述之義務,不論係因新資訊、未來事件或其他原因。接下來進入開場致詞,我將把電話會議交給我們的董事長兼執行長 Joey Jacobs。

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Good morning and welcome to our second-quarter conference call. In addition to Brent I'm here today with our Chief Financial Officer, David Duckworth and other members of our Executive Management Team. David and I each have some brief remarks about the second quarter and our outlook for Arcadia. Then we'll open the line for your questions.

    各位早安,歡迎參加我們的第二季電話法說會。除了 Brent 之外,今天與我一同出席的還有我們的財務長 David Duckworth 以及其他執行管理團隊成員。David 和我將各自就第二季表現以及我們對 Acadia 的展望做一些簡短說明。之後我們將開放提問。

  • Acadia had a great second quarter of 2015. Our financial results reflect the full quarter impact of both our PiC acquisition, completed on July 1 last year, and our CRC acquisition completed February 11 of this year. Primarily as a result of these transactions, our revenues more than doubled to $450 million for the quarter and our adjusted income from continuing operations increased 138%.

    Acadia 在 2015 年第二季表現非常出色。我們的財務結果反映了兩項收購對整季的完整貢獻:去年 7 月 1 日完成的 PiC 收購,以及今年 2 月 11 日完成的 CRC 收購。主要由於這些交易,我們本季營收增加逾一倍至 4.50 億美元,持續營運之調整後收益增加 138%。

  • We also posted adjusted earnings per diluted share of $0.57 which is an increase of 78% and the fourth consecutive quarter of EPS growth over 50%. While the PiC and CRC transactions were pivotal to our second-quarter growth, our results also reflected nine other acquisitions in the last 12 months ending June 30. In aggregate our acquisitions over the one year period doubled our beds by adding 4,300 beds in 8,200 inpatient facilities while also adding 88 comprehensive treatment facilities that serve nearly 46,000 addiction treatment patients per day.

    我們也公布稀釋後每股調整後盈餘(EPS)為 0.57 美元,年增 78%,且已連續第四季 EPS 成長超過 50%。雖然 PiC 與 CRC 交易是推動第二季成長的關鍵,但我們的結果也反映了截至 6 月 30 日止過去 12 個月內另外九項收購。整體而言,我們在這一年期間的收購使床位數倍增:在 8,200 張住院床位的設施中新增 4,300 張床位,同時新增 88 家綜合治療機構,每日服務近 46,000 名成癮治療患者。

  • We have been especially pleased with our growth in the UK. In the first year after acquiring PiC we completed six additional acquisitions in the UK for 22 facilities with over 500 beds. Primarily due to these transactions, PiC operated 45 facilities with over 1,800 beds at the end of the second quarter. After the end of the quarter we also are pleased to expand our services in the UK with the acquisition of our first facility in the market focused on addiction treatment.

    我們對英國業務的成長尤其感到滿意。在收購 PiC 後的第一年,我們在英國又完成六項收購,合計 22 家機構、超過 500 張床位。主要由於這些交易,PiC 在第二季末營運 45 家機構、超過 1,800 張床位。在季末之後,我們也很高興透過收購在英國市場中第一家以成癮治療為主的機構,擴大我們在英國的服務。

  • Arcadia's organic grow strategy also contributed significantly to our profitable growth for the second quarter. To meet increasing market demand we added 500 new beds including one de novo facility in the 12 months ending with the second quarter. We added about 250 of these beds in the first half of 2015 and as we mentioned in the first quarter call we expect to add approximately 400 beds to existing facilities in the US for full-year 2015. Not including the 90 bed de novo facility opened in the first quarter and the 120 bed de novo facility scheduled to open in the third quarter.

    Acadia 的有機成長策略也對第二季的獲利成長做出重大貢獻。為滿足市場需求增加,我們在截至第二季的過去 12 個月新增 500 張床位,其中包含一家新設(de novo)機構。我們在 2015 年上半年新增約 250 張床位;如同我們在第一季電話會議中提到的,我們預期 2015 全年在美國既有機構新增約 400 張床位。上述不包含第一季開設的 90 床新設機構,以及預計第三季開設的 120 床新設機構。

  • We also plan to add more than 100 new beds to existing facilities in the UK in the last half of 2015. Consistent with the business model we've demonstrated over many years, the addition of new beds to our same facility base helped drive 9% growth in same facility revenues for the second quarter. This strong top line growth generated increased operating leverage primarily responsible for 120 basis points increase in same facility EBITDA margin to 26.1%.

    我們也計畫在 2015 年下半年於英國既有機構新增超過 100 張床位。與我們多年來所展現的商業模式一致,在既有機構基礎上增加新床位,帶動第二季同店營收成長 9%。這項強勁的營收成長帶來更高的營運槓桿,並成為同店 EBITDA 利潤率提升 120 個基點至 26.1% 的主要原因。

  • In addition, our consolidated adjusted EBITDA margin rose 240 basis points to 23.3%. We ended the second half of 2015 with strong operating momentum and ample ongoing acquisition and organic growth opportunities. As a result we have increased our guidance for our adjusted EPS for 2015 to a range of $2.15 to $2.18. Which implies growth of 40% to 42% for 2015 compared with 2014.

    此外,我們合併調整後 EBITDA 利潤率上升 240 個基點至 23.3%。我們在 2015 年下半年以強勁的營運動能開局,且持續擁有充足的收購與有機成長機會。因此,我們將 2015 年調整後 EPS 指引上調至 2.15 至 2.18 美元區間。這意味著 2015 年相較 2014 年成長 40% 至 42%。

  • Thank you for your interest in Acadia and now here is David Duckworth.

    感謝各位對 Acadia 的關注,接下來請 David Duckworth 發言。

  • David Duckworth - CFO

    David Duckworth - CFO

  • Thanks Joey and good morning. Arcadia's revenue for the second quarter of 2015 was $453.7 million, a 112.2% increase from $213.8 million for the second quarter of 2014. Adjusted income from continuing operations rose 137.8% to $39.5 million from $16.6 million. Adjusted EPS for the second quarter of 2015 grew 78.1% to $0.57 from $0.32 for the second quarter of 2014.

    謝謝 Joey,各位早安。Acadia 2015 年第二季營收為 4.537 億美元,較 2014 年第二季的 2.138 億美元成長 112.2%。持續營運之調整後收益由 1,660 萬美元增加 137.8% 至 3,950 萬美元。2015 年第二季調整後 EPS 由 2014 年第二季的 0.32 美元成長 78.1% 至 0.57 美元。

  • Our adjusted results exclude transaction related expenses of $7.2 million and $3 million for the second quarters of 2015 and 2014 respectively. They also exclude a $1 million loss on foreign currency derivatives for the second quarter of 2015 and a $13.7 million gain on foreign currency derivatives for the second quarter last year. Weighted average diluted shares outstanding increased 32.6% for the comparable quarters primarily due to our public equity offerings in June 2014 and May 2015 and the February 2015 equity issuance related to the CRC acquisition.

    我們的調整後結果排除 2015 年與 2014 年第二季分別為 720 萬美元與 300 萬美元的交易相關費用。同時也排除 2015 年第二季外匯衍生性金融工具 100 萬美元損失,以及去年第二季外匯衍生性金融工具 1,370 萬美元收益。可比季度的加權平均稀釋後流通在外股數增加 32.6%,主要由於我們於 2014 年 6 月與 2015 年 5 月的公開發行,以及 2015 年 2 月與 CRC 收購相關的股權發行。

  • Arcadia's tax rate on adjusted income from continuing operations, before income taxes, was 31.3% for the second quarter compared with 37.7% for the second quarter of 2014. Which is consistent with our expectation of 32% for full-year 2015. The Company produced a 9% increase in same facility revenues for the second quarter reflecting increases of 7.4% in patient days and 1.5% in revenue per patient day.

    Acadia 持續營運之調整後稅前收益的有效稅率於第二季為 31.3%,相較 2014 年第二季為 37.7%。這與我們對 2015 全年 32% 的預期一致。本公司第二季同店營收增加 9%,反映患者日數增加 7.4%,以及每患者日營收增加 1.5%。

  • Same facility EBITDA margin was 26.1%, up 120 basis points from 24.9% for the second quarter last year. Adjusted consolidated EBITDA rose 136.6% to $105.8 million from $44.7 million, while adjusted, consolidated EBITDA margin increased 240 basis points to 23.3% from 20.9%.

    同一設施 EBITDA 利潤率為 26.1%,較去年第二季的 24.9% 上升 120 個基點。調整後合併 EBITDA 由 4,470 萬美元上升 136.6% 至 1.058 億美元,而調整後合併 EBITDA 利潤率則由 20.9% 增加 240 個基點至 23.3%。

  • As discussed in yesterday's news release we raised our 2015 guidance for adjusted earnings per diluted share to a range of $2.15 to $2.18 from the prior range of $2.11 to $2.15. Our financial guidance excludes the impact from any future acquisitions and transaction related expenses.

    如同昨日新聞稿所述,我們將 2015 年調整後稀釋每股盈餘指引由先前的 2.11 至 2.15 美元,上調至 2.15 至 2.18 美元的區間。我們的財務指引不包含任何未來併購及交易相關費用的影響。

  • This concludes our prepared remarks this morning and thank you for being with us. I'll now ask Kiya to open the floor for your questions.

    以上為我們今天上午的預先準備發言,感謝各位與會。接下來我將請 Kiya 開放現場供各位提問。

  • Operator

    Operator

  • (Operator Instructions)

    (接線員指示)

  • Whit Mayo, Robert Baird.

    Whit Mayo,Robert Baird。

  • Whit Mayo - Analyst

    Whit Mayo - Analyst

  • Thanks, good morning.

    謝謝,早安。

  • There's obviously been some momentum building around a new bipartisan mental health bill, and some discussion around enhanced or expanded funding for medication-assisted treatment for opioid addiction. Just curious if you have any thoughts around those two areas?

    顯然,近期圍繞一項新的兩黨精神健康法案的動能正在形成,並且也有一些關於加強或擴大對鴉片類藥物成癮之藥物輔助治療(MAT)資金支持的討論。想請教你對這兩個領域是否有任何看法?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Whit, this is Joey.

    Whit,我是 Joey。

  • Yes, we are excited and supportive of the legislation that has been introduced both into the House and to the Senate concerning better coverage for mental health and doing away with the IMD. And also about the need to expand for treating opiate addiction. And so we're very positive on both of those.

    是的,我們對已在眾議院與參議院提出、旨在改善精神健康保障並取消 IMD 的立法感到振奮並予以支持。同時也支持擴大治療鴉片類藥物成癮的需求。因此,我們對這兩項都非常正面。

  • We think the country and the payers and the providers realize the need here in this area. And we look forward to working with our Senators and Congressmen and to seeing this legislation move forward. As you know, it's an election year; and everything is tougher in an election year. So we'll just keep our fingers crossed. But it would be a very big positive for us, we think, on both of these areas that you addressed.

    我們認為國家、支付方與服務提供者都已意識到此領域的需求。我們也期待與參議員與眾議員合作,並看到這項立法向前推進。如各位所知,今年是選舉年;選舉年一切都更困難。所以我們只能拭目以待。但我們認為,就你提到的這兩個領域而言,若能通過將會對我們帶來非常大的正面影響。

  • Whit Mayo - Analyst

    Whit Mayo - Analyst

  • Okay, and length of stay came down a bit in the quarter consistent with the trend we've seen, presumably just mix.

    好的,而本季住院天數(length of stay)略有下降,與我們看到的趨勢一致,推測主要是組合因素。

  • Brent, any color around those moving pieces?

    Brent,能否就這些變動因素補充一些說明?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Whit, this is Joey again.

    Whit,我又是 Joey。

  • You have seen our outstanding admission growth, primarily that's acute admissions that's doing that. And actually, our length of stay ticked up a little bit from the first quarter; it went from 15.5, I think, to 15.6. So it's just the mix of the acute patients.

    你已看到我們卓越的入院成長,主要是急性(acute)入院帶動的。而且實際上,我們的住院天數較第一季小幅上升;我記得是從 15.5 增至 15.6。所以這只是急性病患組合的影響。

  • And more of our patients that we are treating today are in the acute side of our business. And as you know, Whit, we've focused on buying acute facilities. And we've focused the majority of our expansion capital for new beds on acute beds. So that's what's making that calculation look like it is.

    而且我們目前治療的病患中,有更多是在我們業務的急性端。如你所知,Whit,我們一直專注於收購急性機構。我們也將大部分用於新增床位的擴張資本投入在急性床位上。因此才會讓這個計算結果呈現出目前的樣子。

  • Whit Mayo - Analyst

    Whit Mayo - Analyst

  • Okay, and maybe just one last one for maybe David or whoever. But your 12 7/8 notes are callable later this year. Just didn't know if you have any updated thoughts around that? Thanks

    好的,最後再問一題,可能給 David 或其他人。你們的 12 7/8 票據今年稍晚可被提前贖回(callable)。想請問你們對此是否有任何最新想法?謝謝。

  • Brent Turner - President

    Brent Turner - President

  • Yes, Whit, those notes are callable -- this is Brent -- on November 1. And given that our subsequent three issues are in the average range of 5.5%, I think it's clearly our intention to call those notes and rebase our interest on that roughly $100 million of debt associated with the 12 7/8.

    是的,Whit,那些票據可被提前贖回——我是 Brent——在 11 月 1 日。鑑於我們後續三次發行的平均利率約在 5.5%,我認為我們顯然有意圖贖回那些票據,並就與 12 7/8 相關、約 1 億美元的債務,將利息成本重新定價至該水準附近。

  • Whit Mayo - Analyst

    Whit Mayo - Analyst

  • Got it. Thanks a lot.

    了解。非常感謝。

  • Operator

    Operator

  • A.J. Rice, UBS.

    A.J. Rice,UBS。

  • A.J. Rice - Analyst

    A.J. Rice - Analyst

  • Thanks.

    謝謝。

  • First of all, maybe just have you speak specifically to CRC. I think you made the comment broadly that it's running in line to better than expectations. Can you just break out maybe, or comment on, some of the things you are seeing that are going particularly well. And if there is any challenges you've unearthed, maybe comment on those?

    首先,想請你們特別談談 CRC。我記得你們大致提到它的表現符合甚至優於預期。能否拆解一下,或評論你們看到哪些方面特別進展順利?如果你們發現任何挑戰,也請一併說明?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • A.J., this is Joey.

    A.J.,我是 Joey。

  • Our CRC acquisition is running ahead of our expectations. And we are pleased every day with the results coming from that acquisition. Ron Fincher, our Chief Operating Officer, and his team have done a stunning job in working on the issues that we had identified. And I think the occupancy now has gone over 80% for that group of assets. So they are growing their census and working on the issues.

    我們對 CRC 的收購案表現優於預期。我們每天都對該收購帶來的成果感到滿意。我們的營運長 Ron Fincher 及其團隊在處理我們先前辨識出的議題上做得非常出色。我認為該資產組合的入住率目前已超過 80%。因此他們正在提升在院人數(census),並處理相關議題。

  • And then the whole team -- Ron, Brent, and David -- the integration is going extremely well; and the synergies are right on track. So CRC is turning out to be the transaction that we wanted it to be. And we have two great leaders there, Joe Procopio and John Peloquin, leading the CRC team. We divided it into two sections and just great.

    此外,整個團隊——Ron、Brent 與 David——整合進展非常順利;協同效益也完全按計畫推進。因此,CRC 正如我們所期望的那樣,成為我們想要的交易。而且我們在那裡有兩位很優秀的領導者,Joe Procopio 與 John Peloquin,帶領 CRC 團隊。我們把它分成兩個部分,表現非常好。

  • There is a lot of momentum. The employees like being with Acadia, and we're seeing that in the results. And, once again, they are ahead of expectations; and there's more momentum there for growth and performance. We have absolutely no issues with this transaction other than they are doing a great job.

    動能非常強。員工喜歡加入 Acadia,我們也在成果中看到了這一點。再次強調,他們的表現優於預期;而且在成長與績效方面還有更強的動能。除了他們做得非常好之外,這筆交易我們完全沒有任何問題。

  • A.J. Rice - Analyst

    A.J. Rice - Analyst

  • And in the UK, I think, in the quarter you announced a small deal, which gets you into addiction services over there. Can you just tell us a little bit more about that? Is that sort of a one-off, or do you see a big opportunity in that area over there?

    另外在英國,我想你們在本季宣布了一筆小型交易,讓你們在那邊切入成癮服務。能否再多談一些?這算是一次性的交易,還是你們認為那邊在該領域有很大的機會?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • We asked about it -- our operators over there, we've asked them about how is addiction treatment being treated there. There are quite a few facilities that just do addiction treatment; and quite a few larger facilities, med/surg facilities, that have some addiction services in them.

    我們曾詢問過——我們在那邊的營運團隊,我們問他們成癮治療在當地是如何被看待與提供的。那邊有相當多只做成癮治療的機構;也有不少較大型的醫療/外科(med/surg)機構,內部提供部分成癮服務。

  • We found this. It's a small facility; it's less than 20 beds. But we found it; this is an R&D for us. We think the location, the quality of the service there that the previous owner had created, we think we can do well with this. And so it's R&D for us, and we think it's going to be a positive. This could be an area where we would consolidate and grow further in the UK.

    我們找到了這個標的。它是一家小型機構;床位不到 20 床。但我們找到了它;這對我們而言屬於研發(R&D)。我們認為其地點、以及前任業主所建立的服務品質,我們有能力把它經營得很好。因此這是我們的研發,我們認為會帶來正面成果。這可能會是我們在英國進一步整併並擴張的領域。

  • A.J. Rice - Analyst

    A.J. Rice - Analyst

  • Okay, and then just finally last one. Just hear your thoughts on any update on the competitive landscape. You are obviously looking at several different geographies, as well as types of services that you are willing to buy. Is there any change or development, either with respect to the prices you are seeing that you have to pay or the competitive landscape for deals?

    好的,最後再問一個。想聽聽您對競爭態勢是否有任何更新的看法。您顯然在看多個不同的地理區域,以及您願意收購的服務類型。無論是就您看到必須支付的價格,或是交易的競爭環境而言,是否有任何變化或發展?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • The prices are competitive. We still find the transaction where we are the only one there. The Belmont facility that we bought in the third quarter, we were the only one doing that transaction. We are the only one that was involved with Southcoast, doing that transaction.

    價格具有競爭力。我們仍然能找到那種交易——現場只有我們一家。我們在第三季買下的 Belmont 設施,那筆交易只有我們在做。Southcoast 那筆交易也只有我們參與。

  • But many of the transactions we see now are coming to us from bankers, but it's different. We are seeing different -- there's not someone like Arcadia always there at the table. It's different groups, smaller groups of individuals, looking at the facility that have an interest in those facilities that we might be acquiring.

    不過,我們現在看到的許多交易是由投行介紹給我們的,但情況有所不同。我們看到的是不同的——不再總是像 Arcadia 那樣的人一直在桌上。而是不同的團體、較小的個人團隊在看這些設施,對我們可能收購的設施有興趣。

  • Once again our balance sheet, our history both with our former Company and with Arcadia, gives us a heads up. And Steve Davidson, our Chief Development Officer, during the past 90 days he's worked me very hard. Had me out on the road visiting the potential acquisitions for us.

    再一次,我們的資產負債表、我們過去在前公司以及在 Arcadia 的歷史,讓我們占得先機。而且在過去 90 天裡,我們的首席開發長 Steve Davidson 讓我忙得不可開交。他帶我到各地拜訪我們潛在的收購標的。

  • So we're very busy sorting through the acquisitions. And we're going to continue to make good, accretive acquisitions for Arcadia. And the pipeline is busy, and Steve is keeping me busy. So we think we will have more acquisitions in the last half of 2015.

    所以我們非常忙於篩選這些收購案。我們也會持續為 Arcadia 進行優質、具增益性的收購。案源管線很活躍,Steve 也讓我一直很忙。因此我們認為在 2015 年下半年會有更多收購。

  • A.J. Rice - Analyst

    A.J. Rice - Analyst

  • Okay, great. Thanks a lot.

    好的,很好。非常感謝。

  • Operator

    Operator

  • Kevin Fischbeck, Bank of America Merrill Lynch.

    美國銀行美林的 Kevin Fischbeck。

  • Joanna Gajuk - Analyst

    Joanna Gajuk - Analyst

  • Good morning. This is Joanna Gajuk filling in for Kevin today.

    早安。我今天代替 Kevin,我是 Joanna Gajuk。

  • Just a question on -- you started talking about the policy or the different policies that are being discussed there. But can you just talk about what you see in terms of the mental health parity impact or anything around coverage expansions or any trends to highlight there?

    想問一個問題——您剛開始談到正在討論的政策或不同政策。但您能否談談您所看到的心理健康同等(parity)影響,或是任何與保障範圍擴大相關的情況,或有沒有什麼趨勢值得特別指出?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Sure, Joanna.

    當然可以,Joanna。

  • On parity, obviously last year the final regs went into place for plan years post July 1, 2014. I think there's just going to be a continuation of adoption of mental health parity. Obviously, there is more access to the patients that have the insurance and more appropriate coverage levels.

    關於同等(parity),顯然去年最終法規已對 2014 年 7 月 1 日之後的計畫年度生效。我認為心理健康同等的採行只會持續推進。顯然,對有保險的病患而言,可近性更高,保障水準也更適切。

  • But we're going to continue to see, as the whole industry will continue to see, incremental benefits as payers and providers get more accustomed to behaving within the rules of mental health parity. And then on the IMD or the Medicaid exemption, there is a lot of momentum there with the CMS announcement under the managed Medicaid regs for the managed Medicaid states to be able to cover Medicaid adults in freestanding psychiatric facilities.

    但我們會持續看到——整個產業也會持續看到——隨著付款方與服務提供者更習慣在心理健康同等規則下運作,所帶來的逐步增益。至於 IMD 或 Medicaid 豁免,CMS 在受管理 Medicaid 法規下的公告帶來很大動能,使受管理 Medicaid 州能夠為 Medicaid 成人在獨立精神科機構中的治療提供給付。

  • That, coupled with the legislation that has already been introduced in the House and is expected to be introduced in the Senate, that would most likely address the IMD exclusion overall. We feel very good about the opportunity for that issue to be resolved in the near future.

    再加上眾議院已提出、且預期參議院也將提出的法案,很可能會從整體上處理 IMD 排除條款。我們對這個議題在不久的將來獲得解決的機會感到非常樂觀。

  • Joanna Gajuk - Analyst

    Joanna Gajuk - Analyst

  • Great.

    很好。

  • And then I've noticed the operating cash flow was very strong. I recall on the first quarter call, you were saying that Q1 was [deeper] than you expect, about $50 million in Q2. But it came even stronger than what you were calling it will be. So any highlights there?

    另外我注意到營運現金流非常強勁。我記得在第一季電話會議上,您提到第一季比您預期更「深」,第二季大約 5,000 萬美元。但實際結果甚至比您當時所說的還要強。這方面有什麼重點可以分享嗎?

  • David Duckworth - CFO

    David Duckworth - CFO

  • Joanna, this is David.

    Joanna,我是 David。

  • It was a great quarter of operating cash flows. The results from same facility and recent acquisitions are a big driver of that being ahead of our expectations. We also see the tax benefit around some of the deal structuring that we have done add to that operating cash flow number for the quarter. And we think it will continue at the second quarter level for the rest of the year.

    這一季的營運現金流表現非常好。同店設施與近期收購的成果,是超出我們預期的主要驅動因素。我們也看到,部分交易架構所帶來的稅務利益,進一步推升了本季的營運現金流數字。而且我們認為今年剩餘期間將可維持在第二季的水準。

  • Joanna Gajuk - Analyst

    Joanna Gajuk - Analyst

  • All right, and then I'm not sure if I missed it; but did you talk about your plans for bed additions for this year in the UK and in the US? The breakdown of things in terms of bed additions? And then maybe if there is any initial view around next year?

    好的,另外我不確定是否漏聽了;但您有談到今年在英國與美國的增床計畫嗎?就增床的拆分來看?以及對明年是否有任何初步看法?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Well, we haven't given out next year's targets. But the list of projects that have already been approved for next year that we are working on is going to look similar to what we're going to do this year. This year, I think we've set the target of doing more than 400 same store beds here in the US and more than 100 over in the UK. And then we have two de novo projects here in the US this year, which are going to add 210 beds this year.

    我們尚未公布明年的目標。但我們已核准、且正在推進的明年專案清單,看起來會與今年要做的相似。今年,我想我們設定的目標是在美國同店增設超過 400 張床位,在英國增設超過 100 張。此外,今年我們在美國有兩個新建(de novo)專案,將在今年增加 210 張床位。

  • We're right at, and slightly ahead of, what we're going to be doing this year -- our goals there. And then, it looks like 2016 is going to look a lot like 2015.

    我們目前的進度正好達標,且略微領先今年要做的——我們在這方面的目標。而且看起來 2016 年會很像 2015 年。

  • Joanna Gajuk - Analyst

    Joanna Gajuk - Analyst

  • And then just lastly, on the color around -- you not seeing any major competitors looking at the same deals as you do? But I guess there is one publicly-traded company that's doing that or concentrated on the addiction center business. So are you competing with them for the deals? Are you seeing any other companies growing in the specialty sector there that could be potential competitors in terms of consolidation on that front? Thanks.

    最後一個問題,關於您提到的——您沒有看到任何主要競爭對手在看與您相同的交易。但我想有一家上市公司也在做,或是聚焦於成癮治療中心業務。所以您在交易上會與他們競爭嗎?您是否看到其他公司在該專科領域擴張,可能成為競爭對手、在整併方面形成競爭?謝謝。

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • There are small, private efforts out there about creating companies. The other publicly-traded company, we've never competed with them on any transaction that I am aware of. So we are looking more for the Sierra Tucson, Bayside Marin, our Blue Ridge facility in Georgia. Ours is a different type of facility that we are looking at, so we have not had them as a competitor.

    市場上確實有一些小型、私人的嘗試在打造公司。至於那家上市公司,就我所知,我們從未在任何交易上與他們競爭過。所以我們更在尋找像 Sierra Tucson、Bayside Marin、以及我們在喬治亞州的 Blue Ridge 設施這類標的。我們看的設施類型不同,因此他們並未成為我們的競爭對手。

  • Joanna Gajuk - Analyst

    Joanna Gajuk - Analyst

  • Okay. Thank you.

    好的。謝謝。

  • Operator

    Operator

  • Gary Lieberman, Wells Fargo.

    Wells Fargo 的 Gary Lieberman。

  • Gary Lieberman - Analyst

    Gary Lieberman - Analyst

  • Good morning. Thanks for taking the question.

    早安。謝謝讓我提問。

  • Can you give us any guidance or maybe some thoughts on how to frame, or potentially frame, the IMD exclusion benefit as we go forward?

    您能否給我們一些指引,或一些想法,讓我們在往後如何理解、或可能如何表述 IMD 排除條款所帶來的效益?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • We're all looking at each other, Gary, about who wants to answer this. It's going to be big. But I think we will start seeing it, as Brent mentioned earlier. We have already seen some of it through the managed Medicaid. We will see it through more as more and more states do the managed Medicaid and the Medicaid adult can come to us. There have been some people out there that've tried to estimate it. We do not spend a lot of time.

    Gary,我們大家互看了一下,看誰要回答這題。這會很大。但我想我們會開始看到它,正如 Brent 先前提到的。我們已經透過受管理 Medicaid 看到其中一部分。隨著越來越多州採行受管理 Medicaid,且 Medicaid 成人可以來到我們這裡,我們會看到更多。外面有些人試著估算其影響。我們沒有花很多時間。

  • We just wanted to know that we have learned how to build and add beds. And we always start our bed projects before we absolutely need them. So if there was to be a greater influx of patients because of IMD or the managed Medicaid, we could handle that until we build enough beds to correct the imbalance there temporarily.

    我們只是想說,我們已經學會如何建置並新增床位。而且我們總是在真正迫切需要之前就啟動床位專案。因此,如果因為 IMD 或受管理的 Medicaid 而出現更大量的病患湧入,我們可以先用現有量能應付,直到我們建出足夠的床位,暫時修正那邊的供需失衡。

  • So I think we could handle it for six months with our capacity and catch up quickly on building additional beds to handle this. But it could be big.

    所以我認為,以我們目前的容量可以撐六個月,並且能快速追上、加速興建額外床位來因應。但規模可能會很大。

  • Gary Lieberman - Analyst

    Gary Lieberman - Analyst

  • Okay, I figured it would be big. Are there any numbers that we could put around that? Any examples of facilities that you have seen a change and that you could, even directionally, help us?

    好的,我想我也預期會很大。有沒有任何數字可以用來量化?有沒有你看過哪些機構出現變化的例子,能不能即使只是方向性地,協助我們理解?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • No, Gary. No, we don't have that data available.

    沒有,Gary。沒有,我們沒有可用的那類資料。

  • Gary Lieberman - Analyst

    Gary Lieberman - Analyst

  • Okay and then maybe just turning to the UK. It sounds like you are still very bullish there. Any updates on reimbursement, or any language from NHS in terms of how they are feeling about the business and the privatization of the business?

    好的,那再轉到英國。聽起來你們對那邊仍然非常看多。在給付方面有任何更新嗎?或 NHS 對於這項業務以及業務私有化的看法,有沒有任何措辭或訊息?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • The NHS is very, very happy with our operations there and the facilities that we have added during the past 12 months to complement the PiC transaction. Rate talk won't begin until, I think, probably February. It has an April 1 effective date over there, so it's too early for any rate talk right now.

    NHS 對我們在那邊的營運,以及過去 12 個月為了補強 PiC 交易而新增的設施,都非常、非常滿意。我想費率方面的討論大概要到二月才會開始。那邊是 4 月 1 日生效,所以現在談費率還太早。

  • But the NHS, it appears we have a very good relationship with them in that they work with us on where their needs are. So very strong relationship with NHS.

    但就 NHS 而言,看起來我們和他們的關係非常好,因為他們會和我們一起討論他們的需求在哪裡。所以與 NHS 的關係非常強。

  • Gary Lieberman - Analyst

    Gary Lieberman - Analyst

  • Okay, great. Thanks very much.

    好的,很好。非常感謝。

  • Operator

    Operator

  • Paula Torch, Avondale Partners.

    Paula Torch,Avondale Partners。

  • Paula Torch - Analyst

    Paula Torch - Analyst

  • Thank you. Good morning. Thanks for taking my question. I had some follow-ups on a couple of questions that have already been answered.

    謝謝。早安。謝謝讓我提問。我有幾個追問,針對先前已經回答過的幾個問題。

  • I'm wondering how difficult it is to open new CTCs and what's the regulatory environment like in CON states and then non-CON states? And do you see any challenges to growth there? And just as a follow-up is there a better chance for acquisitions in this business? Or still opportunities to grow organically here?

    我想了解,開設新的 CTC 有多困難?在需要 CON 的州與不需要 CON 的州,監管環境分別如何?你們是否看到那邊的成長會遇到任何挑戰?另外追問一下:在這個業務中,併購的機會是否更大?或者在這裡仍有機會以有機方式成長?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • No. We will grow both ways. We will make some acquisitions in this area. But also I think we're doing five de novos this year. Hopefully we can up that number to high single digits next year for de novo opportunities. John Peloquin and his teams are all over this about the de novos, so we will be doing both.

    不。我們會兩種方式都成長。我們會在這個領域做一些併購。但同時我想我們今年會做五個新設(de novo)。希望明年新設機會能把數量提高到高個位數。John Peloquin 和他的團隊在新設方面全力投入,所以我們兩邊都會做。

  • States have difference licensing and approval process about getting these licenses to do a de novo. But John and his team know that, just like we do on the acute side. We know certain states have CON's; some of them don't -- the licensing.

    各州在取得這些新設所需執照的核發與審批流程上有所不同。但 John 和他的團隊了解這些,就像我們在急性照護端一樣。我們知道某些州有 CON;有些則沒有——以及相關的執照規範。

  • So we have a pretty good handle on how to get these licenses and the approvals that we need to start the de novo projects for the CTC centers. So we are very bullish here, as we are with the UK. And we will be making acquisitions and doing de novos here too.

    因此,我們對於如何取得這些執照,以及啟動 CTC 中心新設專案所需的核准,掌握得相當好。所以我們在這裡非常看多,就像我們對英國一樣。而且我們也會在這裡進行併購並推動新設。

  • Paula Torch - Analyst

    Paula Torch - Analyst

  • Okay, great. Thank you.

    好的,很好。謝謝。

  • And in the UK, I know that it's small and that it's an R&D. But how big is the addiction market, Joey? And what is the approach to substance use disorders in the UK versus the US? Is it treated differently, and is it all private pay? What's the reimbursement like? Maybe just a little bit more color there?

    另外在英國,我知道規模還小,而且算是研發性質。但成癮治療市場有多大,Joey?英國對物質使用障礙的處置方式,和美國相比如何?治療方式是否不同?是否全部都是自費?給付情況如何?能否再多補充一些背景?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Okay, now you're testing my knowledge or my memory here. It is more private pay, but NHS does pay. Length of stay is similar to what we have here in the States. And there is a larger number of opportunities there in this area than I thought.

    好,現在你是在考驗我的知識或記憶了。那邊比較偏自費,但 NHS 也會支付。住院天數和我們在美國這邊差不多。而且在這個領域的機會數量比我原先想的還多。

  • We've just done a little homework on the UK and did an inventory of who's doing it, who's not doing it. And I was surprised when I saw the report, the number of opportunities that might be available for us for acquisitions. But once again, we are starting with this one facility and see how we do with it. Then we will take it a step at a time.

    我們只是對英國做了一點功課,盤點了有哪些人在做、哪些人沒在做。我看到報告時很驚訝,可能有不少併購機會可供我們切入。但再一次,我們會先從這一家機構開始,看看成效如何。然後我們會一步一步來。

  • Paula Torch - Analyst

    Paula Torch - Analyst

  • Okay, and then maybe one last one for me. I just want to switch to margins for a second. Certainly very strong in the US. Wondering if most of that is from CRC?

    好的,最後再問一個。我想先切換到利潤率談一下。美國這邊當然非常強勁。想請問其中大部分是否來自 CRC?

  • And then as we think about UK margins, they were down a little bit more significantly sequentially than we expected. And is that just due to ramping of the businesses there? I think we saw that in the first quarter. Just wondering if there's anything else you can call out on margins and when we should expect the UK to pick back up to the 26%-27% range?

    另外,談到英國的利潤率,它們的季比下降幅度比我們預期更明顯一些。這是否只是因為那邊業務仍在爬坡期?我想我們在第一季也看到類似情況。想請問在利潤率方面還有沒有其他因素可以點出?以及我們應該何時預期英國能回升到 26%–27% 的區間?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • The UK is most definitely the de novo beds -- the same store beds that we are adding. And some of our smaller acquisitions where we're taking those, those are more of a turnaround where they were not running the same margin as PiC was running. So that gives us more upside.

    英國那邊最主要就是新設床位——也就是我們正在新增的同店床位。另外還有一些較小的併購案,我們接手後比較像是重整(turnaround),因為它們原本的利潤率不像 PiC 那樣。所以這反而給了我們更大的上行空間。

  • If we are successful in continuing to make acquisitions and significant acquisitions in the UK, it is going to be a while before that margin gets back to the old levels because we're going to be growing and getting more margin improvements from the facilities that we are acquiring. So we are very pleased with them, and it is just the waiting of the new acquisitions that we have made there. Joey Chamberlain and her group are doing a great job there.

    如果我們成功在英國持續進行併購、而且是較具規模的併購,那麼利潤率要回到過去水準還需要一段時間,因為我們會持續成長,並從我們收購的機構中逐步取得更多的利潤率改善。所以我們對他們非常滿意,而這只是等待我們在那邊新完成的併購案逐步到位。Joey Chamberlain 和她的團隊在那邊做得非常好。

  • The margins here back in the US -- CRC's margins are very good. But the same-store patient day growth, the 9% revenue growth there, Ron and his team did a great job there. So it's a combination of both. But CRC margins, as we expected, are good, strong. And as I mentioned earlier, we're now over 80% occupancy in that group of assets. So when that happens, margins improve.

    回到美國這邊——CRC 的利潤率非常好。但同店病患日數成長、那邊 9% 的營收成長,Ron 和他的團隊也做得非常出色。所以是兩者的綜合。不過 CRC 的利潤率如我們預期,表現良好且強勁。而且如我先前提到的,我們那一組資產的入住率現在已經超過 80%。當入住率達到這個水準時,利潤率就會改善。

  • Paula Torch - Analyst

    Paula Torch - Analyst

  • Yes, it's a great number. Thank you very much for taking the questions.

    是的,這是個很棒的數字。非常感謝各位提問。

  • Operator

    Operator

  • Brian Tanquilut, Jefferies.

    Brian Tanquilut,Jefferies。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • Good morning. Congratulations.

    早安。恭喜。

  • Joey, I know earlier, or toward the end of the second quarter, you formally guided to the doubling of the revenue outlook for the next three years. So if you don't mind just sharing with us how you view the drivers of that. Meaning what percentage will be organic and how you view the M&A component of that to get to that doubling of the revenue run rate?

    Joey,我知道先前、或在第二季末左右,你們正式指引未來三年營收展望將倍增。所以如果方便的話,請跟我們分享你如何看待其驅動因素。也就是說,有多少百分比會來自有機成長,以及你如何看待併購(M&A)在達成營收年化運行率倍增中的貢獻?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • If you were to take just $2 billion, which we need to add to our existing $2 billion to get to the $4 billion run rate, I think by the end of 2018, what you need to do -- what we did, when we did this, $600 million to $700 million we believe is going to come from organic revenue. And then that leaves about $1.3 billion that Steve will acquire and find for us over the next three years.

    如果只看20億美元——我們需要在既有的20億美元基礎上再增加20億美元,才能達到40億美元的年化運行率——我認為到2018年底,你需要做的——我們當時做這個規劃時——我們相信其中6億到7億美元會來自有機營收。然後就剩下約13億美元,Steve 會在未來三年替我們收購並找出來。

  • So it's about $300 million to $400 million a year in acquisition revenue. However, there are a handful of larger transactions that we could do that makes this much easier. And so we do spend time working those transactions. That's how we get there.

    所以大約是每年3億到4億美元的併購營收。不過,我們也可能做少數幾筆較大型的交易,讓這件事容易很多。因此我們確實會花時間推進那些交易。我們就是這樣達成目標的。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • Okay and then in the UK, you've obviously have been very active on the M&A front, even outside of addiction. How do you see the pipeline there in terms of the size of the deals? And I think it's a more consolidated market than the US is.

    了解。那在英國,你們顯然在併購方面非常積極,甚至不只是在成癮領域。你如何看待那邊的交易管線,就交易規模而言?而且我認為那是一個比美國更集中化的市場。

  • Are there a lot more of these multifacility assets that are up for sale right now, or at least you think will come up for sale in the next 12 months? And should we think of the deal flow being skewed to the UK versus the US?

    目前是否有更多這類多院區資產正在出售,或至少你認為未來12個月會有更多拿出來賣?我們是否應該認為交易流量會偏向英國多於美國?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Nope. It's going to be similar in both places. There are several multifacility transactions that we can do in the UK. And I expect in the next 24 months, we will do one or two of those. So the UK, we will continue to grow.

    不會。兩邊會差不多。英國有好幾筆多院區交易我們可以做。我預期未來24個月我們會做其中一到兩筆。所以英國我們會持續成長。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • Got it.

    了解。

  • And then just for David -- your comment on free cash flow. I know you said for the rest of the year that it looks good. So going forward, is there anything structural that would change your free cash flow profile as we -- and I know you're not giving guidance for 2016, but conceptually, how should we think about free cash flow beyond 2015?

    接著問 David——你提到自由現金流的評論。我知道你說今年剩下的時間看起來不錯。那往後看,是否有任何結構性的因素會改變你們的自由現金流輪廓?我知道你們不提供2016年的指引,但概念上,我們應該如何看待2015年之後的自由現金流?

  • David Duckworth - CFO

    David Duckworth - CFO

  • Yes, Brian, I think what we have seen is that the first quarter and working capital needs there tend to pull just that quarter down a little bit. And then historically, we have seen de novos have an impact. But I would say as we continue to do de novos at a consolidated level, the effect of that won't be as significant as it's been in the past. I think the cash flow number will continue to be strong outside of maybe a slightly lower number in the first quarter.

    是的,Brian,我認為我們看到的是第一季以及相關的營運資金需求,往往會讓那一季的表現稍微被拉低一些。而且歷史上,我們也看到新設據點(de novos)會帶來影響。但我會說,隨著我們持續在合併層級推進新設據點,其影響不會像過去那麼顯著。我認為現金流數字會持續強勁,除了第一季可能會稍微低一點。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • All right, got it. Thanks. Congratulations again.

    好,了解。謝謝。再次恭喜。

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Thanks.

    謝謝。

  • Operator

    Operator

  • John Ransom, Raymond James.

    John Ransom,Raymond James。

  • John Ransom - Analyst

    John Ransom - Analyst

  • I need to learn to hit star one faster because all the smart questions have been asked.

    我得學著更快按下星號一,因為所有聰明的問題都被問完了。

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • John, that means you need to come in first all the time. If you are second, you have already lost. (Laughter)

    John,那表示你得每次都搶第一個進來。如果你是第二個,你就已經輸了。(笑聲)

  • John Ransom - Analyst

    John Ransom - Analyst

  • I believe that's a Ricky Bobby quote right? (Laughter)

    我相信那是 Ricky Bobby 的一句台詞,對吧?(笑聲)

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Good morning.

    早安。

  • John Ransom - Analyst

    John Ransom - Analyst

  • First loser -- remind us how much of the UK market is private versus government owned. And what you think the step down might be in terms of the government turning more and more over to the private sector.

    第一個輸家——提醒我們英國市場中,民營與政府擁有的比例大概是多少?以及你認為政府把更多業務逐步轉交給民間部門時,可能會是怎樣的下移(step down)幅度?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • John, it's roughly just progressionally from the last update, which has probably been 2013 data, I would estimate it's about 15% of the overall mental health services are in the independent sector and then leaving 85% run by the NHS. Everything that we hear and are experiencing reflects, if you will, an acceleration of some of the NHS movement toward relying on the independent sector for the care -- certainly in the intermediate time period. So we don't see that slowing down by any means.

    John,大致上相較於上次更新(可能是2013年的資料)呈現逐步變化;我估計整體心理健康服務中,約15%在獨立部門,剩下85%由NHS營運。我們聽到與親身經歷的一切都反映出——可以這麼說——NHS在某種程度上加速轉向依賴獨立部門來提供照護,至少在中期時間範圍內是如此。所以我們完全看不到這種趨勢有放緩的跡象。

  • John Ransom - Analyst

    John Ransom - Analyst

  • So every, say, 10% NHS steps down, what roughly is the size of that opportunity?

    所以假設NHS每下移10%,那大概對應的機會規模是多少?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Well it's about a $20 billion US market. So that would be roughly about $2 billion of revenue opportunity for the independent sector.

    嗯,這大約是一個200億美元的美國市場規模。所以那大概相當於獨立部門約20億美元的營收機會。

  • John Ransom - Analyst

    John Ransom - Analyst

  • And that does not include addiction? That's just what some of the partners in care was doing?

    而且這不包含成癮?這只是 Partners in Care 在做的那些?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Correct.

    正確。

  • John Ransom - Analyst

    John Ransom - Analyst

  • And do you have any idea of those stats on addiction?

    那你對成癮方面的那些統計有概念嗎?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • I do not have that in front of me, John.

    John,我手邊沒有那些資料。

  • John Ransom - Analyst

    John Ransom - Analyst

  • Is the government involved in providing that care?

    政府有參與提供那類照護嗎?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • No. I am sure they provide some; but it looks like that is, once again, a private side business opportunity. NHS is a payer, but it looks like there is more private-side opportunity there.

    沒有。我確定他們會提供一些;但看起來那又是一個民間端的業務機會。NHS是付款方,但看起來那邊有更多民間端的機會。

  • John Ransom - Analyst

    John Ransom - Analyst

  • And then just my last question would be looking at the US addiction market, which is very large and very unconsolidated. As you assess the market, how many multisite acquisitions that fit your standards and can be had for a reasonable price, what does that look like? And is there a bid-ask spread going on between what you want to pay and what these multisites are looking to get?

    最後一個問題是看美國的成癮市場,它非常大且非常分散。當你評估市場時,符合你們標準、且能以合理價格取得的多據點併購標的有多少?大概是什麼樣的情況?在你們願意支付的價格與這些多據點業者想要的價格之間,是否存在買賣價差(bid-ask spread)?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Obviously, they always think their facility is the best in the world. And we will go through our evaluation and give them a fair price, so there is that give-and-take there. There are, just off the top of my head, I would say 10-plus multifacility opportunities out there, and we are looking at some of those. But there is more than 10.

    很顯然,他們總是覺得自己的機構是全世界最好的。而我們會進行評估並給出公平的價格,所以中間確實會有一些拉鋸。就我腦中粗略估算,我會說外面有10個以上的多院區機會,我們也在看其中一些。但不只10個。

  • John Ransom - Analyst

    John Ransom - Analyst

  • Okay. As I recall, when you bought CRC, they had 600-plus empty beds. I know you had filled around 100 of those by the first quarter. Where does their occupancy stand today compared to when you acquired it?

    好。我記得你們收購CRC時,他們有600張以上的空床。我知道到第一季你們大概填補了其中約100張。相較於你們收購時,他們目前的入住率(occupancy)到什麼程度?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • I don't have the occupancy numbers, but I can tell you on the number of beds I think there was roughly closer to 700 empty beds. And I think we are now down to about 450, somewhere in that area.

    我沒有入住率的數字,但就床位數而言,我想大約接近有 700 張空床。而我認為我們現在降到大約 450 張左右,大概在那個範圍。

  • John Ransom - Analyst

    John Ransom - Analyst

  • Great. Thank you.

    很好。謝謝你。

  • Operator

    Operator

  • Frank Morgan, RBC Capital Markets.

    Frank Morgan,RBC Capital Markets。

  • Frank Morgan - Analyst

    Frank Morgan - Analyst

  • Any thoughts on the psych final rule that came out the other day? Anything in particular that stood out to you as meaningful or noteful?

    對於前幾天公布的精神科最終規則,你有什麼看法嗎?有沒有什麼特別讓你覺得重要或值得注意的地方?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • It was as expected, Frank. Obviously, the original notice came out 60 days ago, generally just inside of a 2% rate increase for the providers. So it was just the finalization of that initial update, and it was as expected.

    如同預期,Frank。顯然,原始公告在 60 天前發布,整體而言對提供者的費率調升大致略低於 2%。所以這只是把那次初始更新定案,結果也如同預期。

  • Frank Morgan - Analyst

    Frank Morgan - Analyst

  • Okay, but nothing structurally different either?

    好的,但在結構上也沒有任何不同嗎?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • No. It was literally just an update of the rate.

    沒有。真的就只是費率的更新。

  • Frank Morgan - Analyst

    Frank Morgan - Analyst

  • Okay, that's fine.

    好的,沒問題。

  • And then one final one. I think you all mentioned tax-advantaged deal structures that helped your tax rate. Could you maybe elaborate just briefly on that? And that's got it, thanks

    然後最後一個問題。我想你們提到一些具稅務優惠的交易結構,幫助了你們的稅率。你能不能簡短說明一下?就這些了,謝謝。

  • David Duckworth - CFO

    David Duckworth - CFO

  • Yes, sure, Frank. This is David.

    好的,當然可以,Frank。我是 David。

  • What we have seen is really a combination of two things that are acquisition-related that have helped make our cash tax rate around 20% to 22% compared to what we see on a GAAP tax rate of around 32%. But what we see is the value of NOLs that we sometimes acquire in a transaction. Notably for this quarter, the CRC transaction brought some NOLs that we have been able to utilize, and will utilize, for about a three-year period.

    我們看到的其實是兩件與併購相關的因素結合,讓我們的現金有效稅率約在 20% 到 22%,相較之下,我們看到的 GAAP 稅率大約在 32%。其中之一是我們在交易中有時會取得的 NOL(淨營運虧損)價值。特別是本季,CRC 這筆交易帶來了一些 NOL,我們已經能夠使用,並且將在約三年的期間內持續使用。

  • And then in certain deals, we also were able to structure the deal to get some deductible goodwill for tax purposes. We don't see that in our GAAP tax rate, but there are tax deductions from that that improve our operating cash flows.

    另外,在某些交易中,我們也能透過交易架構安排,取得在稅務上可扣抵的商譽。這在我們的 GAAP 稅率中看不到,但由此產生的稅務扣除額能改善我們的營運現金流。

  • Frank Morgan - Analyst

    Frank Morgan - Analyst

  • Okay. Thank you.

    了解。謝謝你。

  • Operator

    Operator

  • Dana Hambly, Stephens.

    Dana Hambly,Stephens。

  • Dana Hambly - Analyst

    Dana Hambly - Analyst

  • Thank you.

    謝謝。

  • Joey, on the acquisitions, thinking about the different segments. Obviously, the UK is a big opportunity; the addiction, big opportunity. But maybe I'm wrong; I'm hearing less on the acute inpatient. Are you not seeing the same quality or the same size of the portfolio?

    Joey,關於併購,從不同事業區塊來看。顯然,英國是很大的機會;成癮治療也是很大的機會。但也許是我理解錯了;我聽到關於急性住院的部分比較少。你們是不是沒有看到同樣的品質或同樣規模的資產組合?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • No. Let me clean that up. We are looking at terrific acute facilities in the US, and from standalones to multifacility.

    不是的。我來釐清一下。我們正在看美國非常出色的急性照護機構,從單一院所到多院所的組合都有。

  • Dana Hambly - Analyst

    Dana Hambly - Analyst

  • Okay, very good. I just misunderstood.

    好的,非常好。是我誤會了。

  • And looking at the non-same-store margins, they've been running north of 30% the last couple of quarters. Obviously, a lot of CRC. I thought that you had talked about those margins being more like in the mid-20%s, so of course you are performing above expectations. Is that something, though, that could actually go higher if you can get the occupancy up?

    再看非同店的利潤率,過去幾季都在 30% 以上。顯然有很大一部分來自 CRC。我記得你們之前談到那些利潤率比較像是 20% 中段,所以當然你們的表現超出預期。不過,如果你們能把入住率拉高,那個利潤率是否其實還能更高?

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • We have seen that as a higher occupancy you run, the margins do improve. But once again, you have to achieve that higher occupancy; and we're constantly building and adding beds. So if we were to just stop and just focus on occupancy and just driving it, that would be a short-term; and margin may go up some.

    我們確實看到,入住率越高,利潤率就會改善。但再說一次,你必須先達到更高的入住率;而我們也在持續建置並增加床位。所以如果我們只是停下來、只專注在入住率並推動它,那會是短期作法;利潤率可能會上升一些。

  • But we want to build our beds and grow our total revenues from those new patient days. But our margins are good.

    但我們希望擴增床位,並透過新增的病人日來成長我們的總營收。不過我們的利潤率表現不錯。

  • Dana Hambly - Analyst

    Dana Hambly - Analyst

  • Yes, they are. Thank you very much.

    是的,確實不錯。非常感謝。

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Thanks.

    謝謝。

  • Operator

    Operator

  • And we have no further questions in queue at this time. I would now like to turn the conference back over to Joey Jacobs for any additional or closing remarks.

    目前排隊中沒有其他問題。我現在想把電話交回給 Joey Jacobs,請他做任何補充或結語。

  • Joey Jacobs - Chairman & CEO

    Joey Jacobs - Chairman & CEO

  • Sure.

    好的。

  • I must give out a thanks to all of our 20,000-plus employees and clinicians that work at our facilities. Thank you all very much for what you do every day, and the number of patients that we take care of. You all are what's making Arcadia very, very, very successful.

    我必須向我們在各院所工作的 20,000 多名員工與臨床人員致謝。非常感謝大家每天所做的一切,以及我們所照護的病人數量。正是各位讓 Arcadia 非常、非常、非常成功。

  • To Ron and his team on the stunning performance they gave us in the second quarter. I did happen to visit three facilities. I went out to Desert Springs. Carol Bickelman, our CEO there, we cut the ribbon on a brand-new replacement facility there for her and her team. Just outstanding work she is doing.

    也要感謝 Ron 和他的團隊在第二季帶給我們的亮眼表現。我剛好參訪了三家院所。我去了 Desert Springs。那裡的執行長 Carol Bickelman,我們為她和她的團隊在那裡全新的替代院區舉行剪綵。她所做的工作真的非常出色。

  • Bill Parsons up at Southcoast in Massachusetts, which we're going through the process right now of opening that new 120-bed facility. Bill and his team and our Southcoast partners, just going terrific there. And to Dr. Kim Dennis, our CEO of Timberline Knolls up in Chicago. She happened to come down last week and present to our Board, and we were up visiting with her about a month ago. Just a great job she continues to do there and what that facility does for its many, many, many patients.

    還有麻薩諸塞州 Southcoast 的 Bill Parsons,我們目前正在推進開設那座新的 120 床院區。Bill、他的團隊以及我們的 Southcoast 合作夥伴,進展都非常順利。另外也要感謝位於芝加哥的 Timberline Knolls 執行長 Kim Dennis 醫師。她上週剛好下來向我們董事會簡報,而我們大約一個月前也去拜訪她。她持續在那裡做得非常好,而那家院所也為其眾多、眾多、眾多的病人提供了重要服務。

  • So once again thank you all very much. Thank you for being on the call with us today, and we will talk to you the end of the third quarter.

    所以再次非常感謝大家。謝謝各位今天參與我們的電話會議,我們將在第三季結束時再與各位交流。

  • Operator

    Operator

  • And this does conclude today's conference call. Thank you all for your participation. You may now disconnect.

    今天的電話會議到此結束。感謝各位的參與。各位現在可以掛線。